Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 2, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 22
- −1 vs. Q1 2023
- Portfolio value
- $322.1M
- +$14.6M (+4.8%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $67.6M | 21.0% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 814,586 | $56.2M | 17.5% | −814,587−50.0% | Reduced | History |
| CVRXCVRx, Inc. | COM | 3,495,575 | $54.0M | 16.8% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 6,641,064 | $44.6M | 13.9% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $18.7M | 5.8% | 00.0% | Unchanged | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,670,516 | $17.1M | 5.3% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $16.1M | 5.0% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 357,939 | $12.7M | 3.9% | 00.0% | Unchanged | History |
| PNTPOINT Biopharma Global Inc. | COM | 1,000,000 | $9.06M | 2.8% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 247,598 | $8.83M | 2.7% | 00.0% | Unchanged | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 317,704 | $4.92M | 1.5% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 1,074,658 | $3.32M | 1.0% | 00.0% | Unchanged | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 394,834 | $3.31M | 1.0% | 00.0% | Unchanged | History |
| HLTHCue Health Inc. | COM | 5,548,864 | $2.05M | 0.6% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 728,944 | $1.77M | 0.5% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 2,133,402 | $768.0K | 0.2% | 00.0% | Unchanged | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 281,052 | $649.2K | 0.2% | 00.0% | Unchanged | History |
| CLSDClearside Biomedical, Inc. | COM | 169,629 | $190.0K | 0.1% | 00.0% | Unchanged | History |
| APLMApollomics Inc. | CL A SHS | 13,252 | $75.9K | <0.1% | 00.0% | Unchanged | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $41.7K | <0.1% | 00.0% | Unchanged | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 84,003 | $24.4K | <0.1% | 00.0% | Unchanged | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 66,951 | $23.5K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2023 (1)
Positions held at the end of Q1 2023 that are gone from this filing.